Investors Land CLVS Even Cheaper Than Its Secondary Stock Offering
October 16, 2017 at 11:23 AM EDT
Looking back to 118 days ago, Clovis Oncology Inc (CLVS) priced a 3,409,091 share secondary stock offering at $88.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..